Adding dalpiciclib to adjuvant endocrine therapy can improve outcomes in patients with HR-positive, HER2-negative early breast cancer.

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it.

Several young celebrities have announced breast cancer diagnoses in the past year — a public reminder that rates are rising among women under 50 in the U.S.

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...

When former President Joe Biden revealed he had been diagnosed with prostate cancer earlier this year, it reignited a ...

High testosterone in women can stem from conditions like PCOS and insulin resistance. Symptoms may include acne, excess hair ...

As with the drug's 2023 approval in castration-resistant tumors, it's not clear if it works comparably in all homologous ...

A study has found that estrogen creams may improve survival rates, despite previous fears they could stimulate cancer cell ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.